Prevalence estimates for chronic urticaria in the United States: A sex- and age-adjusted population analysis.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 30872154.
- Also identified by DOI 10.1016/j.jaad.2019.02.064.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Disease burden in chronic urticaria (CU) is poorly understood. To estimate standardized overall and sex-, age-, and race-specific prevalence estimates for CU among adults in the United States. A cross-sectional analysis with electronic health records data for a demographically heterogeneous population-based sample of >55 million patients across all 4 census regions. The overall CU prevalence was 0.23%, or 230 CU cases/100,000 adults. The adjusted prevalence in women was 310 (95% confidence interval [CI] 307-312) cases/100,000 adults, more than twice that of men (146 [95% CI 143-148] cases/100,000 adults, P < .001). CU prevalence was highest among patients aged 40-49 years (256 [95% CI 252-261] cases/100,000 adults) and 50-59 years (246 [95% CI 242-251] cases/100,000 adults) compared with all other age groups (P < .0001). Adjusted prevalences for black (292 [95% CI 285-298] cases/100,000 adults) and other (331 [95% CI 323-338] cases/100,000 adults) patients were higher than that for white patients (262 [95% CI 260-264] cases/100,000 adults; P < .001). Use of administrative data has the potential to underestimate burden. There are >500,000 people estimated to have CU in the United States, most of whom are women or adults ≥40 years of age.
Medical subject headings
- Cost of Illness
- Ethnicity
- Urticaria